// App-Quantinova.ai

3153 : A new circulating plasma/serum Epstein-Barr virus (EBV) DNA test by locked nucleic acid (LNA) PCR technique with enhanced sensitivity in diagnosis & monitoring of patients suffering from nasopharyngeal carcinoma (NPC) and other EBV associated malignancies

Researchers

Presenter

  • Timothy T.C. Yip

Principal Investigators

  • Hazel Y.Y. Kwok

  • Sharon S.Y. You

  • Dora L.W. Kwong

  • Alvin H.W. Fong

  • W.W. Cheng

  • Christopher Lai

  • Anthony C.C. Shek

  • Victor W.S. Ma

  • Maria Li Lung

  • Roger K.C. Ngan

Medical Centers

  • Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong

  • Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong

  • Clinical Oncology Dept, University of Hong Kong, Pokfulam, Hong Kong

  • Pathology Dept, Queen Mary Hospital, Pokfulam, Hong Kong.

Locations

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Nasopharyngeal carcinoma

  • T-cell lymphoma

  • Solid malignancies

  • Lymphomas

  • Pulmonary lymphoepithelioma-like carcinoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved